Shanghai East Hospital, Tongji University

Shanghai 200120

2 studies enrolling now · 4 studies all time

What they study most

Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung, Diffuse Large B-Cell Lymphoma, Endometrial Neoplasms, Intracranial Hemorrhages, Neoplasm Metastasis, Non-small Cell Lung Cancer (NSCLC), Small Cell Lung Carcinoma, Triple Negative Breast Cancer

Studies at this site

• A Study of LY4175408 in Participants With Advanced Cancer — Recruiting now
• Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs — Recruiting now
• A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma — Completed
• EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) — Running, not enrolling